The Recall Desk
HighFDA (Drugs)·D-0293-2015·Announced 2014-12-17

Baxter Recalls Famotidine Injection Due to Plastic and Rubber Particulate Matter

Baxter Healthcare is recalling 19,152 containers of Famotidine Injection 20 mg due to a complaint reporting the presence of plastic and rubber particulate matter.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a risk-of-harm product (injection containing foreign particulate matter) where injury has not yet been reported, fitting the High severity criteria.

Plain-English summary

Baxter Healthcare Corporation is recalling 19,152 containers of Famotidine Injection 20 mg, a prescription-only intravenous medication. The product is packaged in Galaxy Single Dose Containers with NDC 0338-5197-41. The specific lot affected is NC082768, which has an expiration date of 12/23/2014.

The recall was initiated after Baxter received a complaint reporting the presence of particulate matter in the premixed containers. The particulate matter was identified as plastic or rubber. The affected product was distributed nationwide.

Healthcare providers and patients should stop using the affected lot of Famotidine Injection. Baxter Healthcare is the recalling firm responsible for this action.

The recalled product

Product
FAMOTIDINE (FAMOTIDINE)
Brand
FAMOTIDINE
Affected units
19,152

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: NC082768
  • Exp 12/23/2014

Distribution

Distributed nationwide across the United States.